In the course of our studies aimed to decipher the biological properties of PARP3, we compared the expression of PARP3 in a series of human breast cancer cell lines of distinct subgroups with predominantly luminal (luminal), mixed luminal/basal (basal A) and basal (basal B) features [6]. This evidence concerns the gene PARP3 and breast carcinoma.